health

FDA Approves First Daily Obesity Pill; The Revolution Remains, As Ever, Two Weeks From Scale

The FDA approved Eli Lilly's orforglipron (Foundayo), the first daily oral GLP-1 obesity pill with no food or water restrictions, on 1 April 2026. Widespread access, as always, is approximately two weeks away.

By The 2weeker Administration · Jul 13, 2026

health

FDA Posts Food-Safety Recalls July 6–7, All-Clear Two Weeks From The Lab Results

The FDA posted food-safety actions on 6–7 July 2026, including a GreenWise frozen-blueberry E. coli investigation and an Ola-Ola pounded-yam allergen recall. The all-clear is, as ever, two weeks from the test results.

By The 2weeker Administration · Jul 13, 2026